← Back to Clinical Trials
Recruiting NCT06130956

NCT06130956 The Effect of a 2-week Preoperative Vegan Diet Versus Omnivorous Diet on the Protein Turnover in the Osteoarthritic Knee

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06130956
Status Recruiting
Phase
Sponsor Wageningen University
Condition Osteo Arthritis Knee
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-10-22
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Vegan dietOmnivorous diet

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-10-22 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Rationale: Protein from plant-based foods may be unable to stimulate protein synthesis due to a suboptimal essential amino acid content and a lower digestibility. However, a more optimal amino acid profile may be achieved by increasing portions sizes and blending multiple plant-based sources. Studies investigating the anabolic properties of vegan diets (total elimination of animal-based foods) rather than single plant-based foods in older adults are scarce. It remains unknown if a vegan diet can also affect protein synthesis rates in other musculoskeletal tissues than muscle. Primary objective: To assess the effects of a 2-week preoperative vegan diet in comparison to an omnivorous diet on protein synthesis rates in Hoffa's fat pad, synovium, tendon, bone, ligaments, menisci, and cartilage in older adults with knee osteoarthritis undergoing total knee arthroplasty. Secondary objective: To assess the effects of a 2-week preoperative vegan diet in comparison to an omnivorous diet on blood pressure and plasma amino acids in older adults with knee osteoarthritis undergoing total knee arthroplasty. Study design: Multi-center, randomized, controlled trial with an intervention and a control group. Study population: 40 older adults (60 - 80 years) with osteoarthritis of the knee undergoing total knee replacement. Intervention: Controlled vegan diet versus controlled omnivorous diet, for a duration of 14 days. Main study parameters/endpoints: Primary study parameters are protein synthesis rates of Hoffa's fat pad, synovium, tendon, bone, ligament, menisci, and cartilage. Secondary parameters include blood pressure and plasma amino acids.

Eligibility Criteria

Inclusion Criteria: * Written informed consent; * Patients scheduled for total knee arthroplasty; * BMI between 20-32 kg/m2; * Aged 60 - 80 years; * Mentally competent, as judged by the treating physician; Exclusion Criteria: * Following a vegetarian or vegan diet or a diet that affects protein intake during the six months prior to the study; * Participating in a structured progressive exercise training program in the past three months; * Lost more than 4 kg body weight during three months prior to the study; * Chronic use of medications that affect protein metabolism (i.e. systemic corticosteroids, or prescription strength acne medications); * Being diagnosed with one of the following: diabetes mellitus, rheumatoid arthritis, peripheral artery disease Fontaine III or IV, COPD GOLD III or IV, neoadjuvant chemotherapy or radiotherapy, phenylketonuria, collagen disorders (e.g. Marfan and Ehler-Danlos); * Alcohol abuse; * Surgical intervention to the knee in the past four weeks; * Total parenteral nutrition at day of surgery; * Glomerular filtration rate (GFR) \<20 mL/min/1.73 m2; * Allergic or intolerant to any product included in the diets; * Osteoarthritis of the knee secondary to septic arthritis, osteonecrosis, fracture, osteochondritis dissecans, or malignant processes; * Any other medical condition that may interfere with the safety of the participants or the outcome parameters, in the investigators judgement; * Not willing to stop nutritional supplements, with the exception of vitamin D and supplements on medical advice. * Investigator's uncertainty about the willingness or ability of the participant to comply with the protocol instructions; * Participation in other studies that may have an impact on the outcomes during the three months before the start of the current study.

Contact & Investigator

Central Contact

Inge Groenendijk, PhD

✉ inge.groenendijk@wur.nl

📞 +31628748271

Principal Investigator

Lisette de Groot, PhD

PRINCIPAL INVESTIGATOR

Wageningen University

Frequently Asked Questions

Who can join the NCT06130956 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, up to 80 Years, studying Osteo Arthritis Knee. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06130956 currently recruiting?

Yes, NCT06130956 is actively recruiting participants. Contact the research team at inge.groenendijk@wur.nl for enrollment information.

Where is the NCT06130956 trial being conducted?

This trial is being conducted at Arnhem, Netherlands, Ede, Netherlands.

Who is sponsoring the NCT06130956 clinical trial?

NCT06130956 is sponsored by Wageningen University. The principal investigator is Lisette de Groot, PhD at Wageningen University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology